Canaccord Genuity Upgrades Repro Med Systems to Buy Rating From Hold, Adjusts Price Target to $4 From $3
Canaccord Genuity Upgrades Repro Med Systems to Buy Rating From Hold, Adjusts Price Target to $4 From $3
Canaccord Genuity 将 Repro Med Systems 的评级从持仓上调至买入,将目标价从 3 美元调整为 4 美元
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册